InvestorsHub Logo
Followers 21
Posts 2927
Boards Moderated 0
Alias Born 01/27/2022

Re: rosemountbomber post# 427117

Tuesday, 07/23/2024 3:17:20 PM

Tuesday, July 23, 2024 3:17:20 PM

Post# of 429263
But maybe it will add some firepower to Vascepa's efficacy? Can't think of a reason why they would report on it, otherwise.

Strange that they are doing it at the ALZ conference. I would think even CTAD would have been a better venue for that (CTAD is more scientific focused than ALZ Conference).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News